Articles by Kate Travis

Table: Selected TLR Ligands in Clinical Trials Product Target Manufacturer Condition Phase Intervention Status CPG7909 TLR9 Coley Pharmaceutical Group Lymphoma I/II CpG injections and radiotherapy http://www.clinicaltrials.gov/ct/show/NCT00185965 Ongoing Coley/Pfizer Metastatic breast cancer, renal cell cancer, T-cell lymphoma, non-small cell lung cancer, melanoma I or II CpG injection with or without chemotherapy http://www.cli

Deciphering Immunology's Dirty Secret Can innate immune adjuvants save vaccinology? By Kate Travis ARTICLE EXTRAS 1 Why, he wondered, did scientists have to include bits of bacteria or aluminum hydroxide with a vaccine to get an immune response? Janeway hypothesized and later proved that so-called pattern recognition receptors identify invading pathogens and trigger an immediate reaction against the i

Drop in support is reflected in fewer industry-academia papers and fewer patents for academic institutions, NSF report states

FEATURE Eat Your Way to Better DNA RICK CONTRERAS Why what your grandmother ate while pregnant with your mother might affect your children's health, and other findings from the growing field of nutrigenomics. By KATE TRAVIS Jose M. Ordovas has been studying the role of lipoproteins in heart disease for decades. His laboratory and others have tried to tease out how these proteins factor into why some people can eat an unheal

RELATED ARTICLE A Genetic Diet By the Numbers ANDREW MEEHAN and RICK CONTRERAS While a complete picture of the relationship between food, genes and complex disease has yet to be worked out, several stats point to the benefits nutrigenomic predictions might have for human health. By KATE TRAVIS ARTICLE EXTRAS Feature Article: Eat Your Way to Better DNA Related Article: NuGO: A Vision for Nutrigenomics Collaboratio